Home › Funds › Drexel Morgan & Co. › ABBV

Drexel Morgan & Co. position in ABBV

ABBVIE INC · Health Care

Drexel Morgan & Co. reported holding 1,900 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$497K, representing 0.07% of its reported portfolio and ranking #49 among its reported holdings. Drexel Morgan & Co. has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.90K sh
Reported value held$497.02K
Portfolio Weight0.07%
First reportedQ3 2023
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Drexel Morgan & Co.'s ABBV position evolved

Drexel Morgan & Co. first disclosed a stake in ABBV in Q3 2023 at 1,350 shares (US$201K). The position peaked in Q3 2026 at 1,900 shares, worth US$497K. Across 13 filings, Drexel Morgan & Co. increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 10 time(s). The most recent filing (Q3 2026) shows 1,900 shares valued at US$497K.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.35K $201.23K New
Q4 2023 1.61K $249.35K Add
Q1 2024 1.61K $293.00K Hold
Q2 2024 1.90K $325.89K Add
Q3 2024 1.90K $375.21K Hold
Q4 2024 1.90K $337.63K Hold
Q1 2025 1.90K $398.09K Hold
Q2 2025 1.90K $352.68K Hold
Q3 2025 1.90K $439.93K Hold
Q4 2025 1.90K $434.13K Hold
Q1 2026 1.90K $413.23K Hold
Q2 2026 1.90K $478.12K Hold
Q3 2026 1.90K $497.02K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 31 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$38.97B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has Drexel Morgan & Co. held ABBV?

Drexel Morgan & Co. has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Drexel Morgan & Co.'s current position in ABBV?

As of Q3 2026, Drexel Morgan & Co. holds 1.90K shares of ABBV (ABBVIE INC), valued at $497.02K, representing 0.07% of its reported portfolio and ranking #49.

Has Drexel Morgan & Co. been buying or selling ABBV?

In the latest 13F filing (Q3 2026), Drexel Morgan & Co. held unchanged its position in ABBV. The position peaked in Q3 2026 at 1.90K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.